Statistics for A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2
Total visits
| views | |
|---|---|
| A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2 | 3 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 1 |
File Visits
| views | |
|---|---|
| java.util.UUID:da4ae262-f47b-4c00-a750-385c12c17499 | 31 |
| 41563_2022_Article_1464.pdf | 21 |
| java.util.UUID:895ee687-10d8-4f78-a925-6a8ace0c9658 | 16 |
| java.util.UUID:50dd4bb2-1416-44dc-a37a-ef1df6edfde9 | 5 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |
| Williamsburg | 1 |